Medically reviewed by Gagandeep Brar, MD Stage 1 and 2 prostate cancer stays in your prostate, and the five-year survival rate is over 99%.Stage 4 prostate cancer is not curable, but treatment can ...

In TODAY.com’s Expert Tip of the Day, a doctor explains why patients with early, slow-growing prostate cancer may be able to ...

Personalized dosing for late-stage prostate cancer treatments is critical for balancing toxicity with aggressiveness. Yet, ...

Medically reviewed by Gagandeep Brar, MD End-stage prostate cancer can cause urinary symptoms, including blood in your urine and frequent urination.When prostate cancer spreads to your bones, it can ...

Long-used imaging strategies such as computed tomography (CT) and bone scintigraphy (BS) to detect lymph node and bone metastases have significant limitations and disadvantages. Newly emerging ...

A retrospective study found that preoperative imaging methods all had limited sensitivity for detecting lymph node invasion in patients with intermediate-risk prostate cancer. However, ...

Over the past decade or so, prostate-specific membrane antigen (PSMA) PET/CT has increasingly replaced conventional imaging in men with biochemical recurrence after radical prostatectomy. PSMA PET/CT ...

Add Yahoo as a preferred source to see more of our stories on Google. CHICAGO — Ten years after major changes in the recommendation for prostate cancer screening, a new analysis finds a sharp increase ...

Bone scans have been found to overstage prostate cancer at initial staging compared to prostate-specific membrane antigen (PSMA) PET, according to new research published in the November issue of the ...